Caribbean Epidemiology Centre

 

Page 2                    
WHAT IS MENINGOCOCCAL MENINGITIS?

Meningococcal meningitis is caused by infection with the bacterium Neisseria meningitidis [the meningococcus]. Meningococci are common bacteria, which are "carried" in a person's throat or nose. This bacterium is only found in people and never in animals or in the general environment. Most people who harbour these bacteria have no symptoms of disease. It is not entirely understood why some people become ill following carriage of Neisseria meningitidis, while others do not. Cases can occur sporadically and in epidemics. Children and young adults are most affected.

There are many different strains or serogroups of Neisseria meningitidis and these have been classified into groups, namely, A, B, C, Y, W-135, X and Z. In Trinidad and Tobago, all but one of the bacterial serogroups associated with meningococcal meningitis since 1998, have been identified as Group B.

HOW CAN MENINGOCOCCAL MENINIGITIS BE PREVENTED?

VACCINATION

While effective vaccines are available against Neisseria meningitidis serogroups A, C, Y and W-135, it must be appreciated that vaccines will only abort or control outbreaks caused by the specific serogroups contained in the vaccine. There is currently no licensed vaccine effective against group B meningococci.

It must be emphasised that there are vaccines available against some of the other organisms, which cause bacterial meningitis. These include vaccines against Hemophilus influenzae b [Hib] and Streptococcus pnuemoniae. These vaccines, however, do not protect against infection by the meningococci.

Special antibiotics are available for persons who have been in close contact with cases of meningococcal disease. These antibiotics, which are used to prevent the close contacts from developing the disease, should be administered as soon as possible [ideally within 24 hours of the case having been identified]. Close contacts would therefore include, for example:

Household members
Day-care centre contacts
Anyone directly exposed to the patient's oral secretions [such as a boyfriend or girlfriend] or respiratory droplets.

WHAT SAFETY PRECAUTIONS CAN BE TAKEN TO PREVENT THE SPREAD OF MENINGO- COCCAL MENINIGITIS?

  1. Avoid overcrowding.
  2. Do not share drinking bottles, glasses, cigarettes, lipsticks or other items that may be covered in saliva.
  3. Avoid smoky and dusty places.
  4. Teach children not to share cups, soft drink cans or sports water bottles.
previous page 1 - next page 3
 

Home Search Page
CAREC Home Page ] 25th Anniversary Celebrations ] World AIDS Week ] 1999 Annual Report ] [ Overview of Health in the Region ] Caribbean Health Trends ] Surveillance Report ] About Us ] Data/Statistics Archives ] Travel Health ] Vacancies ] Programmes ] Publications ] Case Investigation Forms ] Links ] Upcoming Events ] Disclaimer ] CAREC Home Page ] Search Page ]

Caribbean Epidemiology Centre
16-18 Jamaica Boulevard, Federation Park,
Republic of Trinidad and Tobago
Tel: (868) 622-4261, Fax: (868) 622-2792
E-mail: postmaster@carec.paho.org

Page last modified 15 August, 2000

 

 


Caribbean Epidemiology Centre
16-18 Jamaica Boulevard, Federation Park
P.O. Box 164, Port of Spain
Republic of Trinidad and Tobago
Tel: (868) 622-4261, Fax: (868) 622-2792
E-mail: postmaster@carec.paho.org

Page last modified 04 December, 2001